Breast cancer
194 results
1 - 100
Breast cancer - Essentials
- Epidemiology
- Rehabilitation
- Follow-up
- Pregnancy and breast cancer
- Hormone replacement therapy
- Treatment of recurrent and advanced cancer
- References
- Aetiology and risk factors
- Symptoms
- Diagnosis
- Histology
- Surgical treatment
- Early postoperative complications
- Oncological adjuvant treatment
- Breast reconstruction
- Bisphosphonates in breast cancer
- Self examination for breast cancer
- Screening for breast cancer with mammography
- Breast cancer and hormonal contraceptives
- Genetic susceptibility to breast cancer
- Essentials
- Criteria for referral to a clinical geneticist
- Genetic testing for susceptibility to breast cancer
- Surveillance of gene mutation carriers
- BRCA1 and BRCA2 gene mutations
- High or moderate risk PALB2, CHEK2 and ATM gene mutations
- Cancer susceptibility syndromes involving (also) susceptibility to breast cancer
- Multifactorial susceptibility
- References
- Prophylactic mastectomy for the prevention of breast cancer
- Radiotherapy and surgery in early breast cancer
- Ovarian ablation in early breast cancer
- Oncoplastic breast‐conserving surgery for women with primary breast cancer
- Physical activity and risk of breast cancer
- Menopausal hormone therapy and breast cancer
- Tamoxifen for premenopausal early breast cancer
- Breast-conserving surgery vs mastectomy in early-stage breast cancer
- Menopausal hormone therapy after breast cancer
- Psychological interventions for women with breast cancer
- Taxane containing regimens for metastatic breast cancer
- Cytotoxic and hormonal treatment for metastatic breast cancer
- Strategies for increasing participation in community breast cancer screening
- Trastuzumab containing regimens for early breast cancer
- Follow-up of treated early breast cancer
- Plastic surgical management of ductal breast cancer - Image
- Exercise for women receiving therapy for breast cancer
- Fulvestrant for hormone-sensitive metastatic breast cancer
- Platinum containing regimens for triple-negative breast cancer
- Axillary treatment for operable primary breast cancer
- Taxanes for adjuvant treatment of early breast cancer
- Progestogens and other hormone therapies in women with breast cancer and bone metastasis
- Cyclin-dependent kinase inhibitor for advanced breast cancer
- Physical therapist management of lymphoedema following treatment for breast cancer
- Antitumour antibiotic containing regimens for metastatic breast cancer
- The effects of physical exercise in women in treatment for or survivors of breast cancer
- Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women
- Combined chemo-endocrine adjuvant therapy for patients with operable breast cancer
- Aromatase inhibitors vs. tamoxifen in postmenopausal women with early breast cancer
- Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery
- Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer
- PARP (poly ADP‐ribose polymerase) inhibitors for locally advanced or metastatic breast cancer
- Sentinel lymph node biopsy in early-stage breast cancer
- Exercise interventions for upper-limb dysfunction due to breast cancer treatment
- Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
- Non-hormonal interventions for hot flushes in women with a history of breast cancer